|
MLX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.023800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.656400E-01 |
| Normal-vs-Stage2 |
9.196400E-01 |
| Normal-vs-Stage3 |
3.167600E-01 |
| Normal-vs-Stage4 |
6.330000E-01 |
| Stage1-vs-Stage2 |
5.534400E-01 |
| Stage1-vs-Stage3 |
5.798200E-01 |
| Stage1-vs-Stage4 |
4.234000E-01 |
| Stage2-vs-Stage3 |
3.790600E-01 |
| Stage2-vs-Stage4 |
7.596000E-01 |
| Stage3-vs-Stage4 |
3.133600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.654400E-01 |
| Normal-vs-AfricanAmerican |
4.818800E-01 |
| Normal-vs-Asian |
8.574000E-01 |
| Caucasian-vs-AfricanAmerican |
8.890400E-01 |
| Caucasian-vs-Asian |
9.113200E-01 |
| AfricanAmerican-vs-Asian |
8.580400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.814800E-01 |
| Normal-vs-Female |
1.331160E-01 |
| Male-vs-Female |
5.071600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.399790E-01 |
| Normal-vs-Extreme_Weight |
3.947600E-01 |
| Normal-vs-Obese |
4.060600E-01 |
| Normal-vs-Extreme_Obese |
5.666600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.713000E-01 |
| Normal_Weight-vs-Obese |
4.851200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.714600E-01 |
| Extreme_Weight-vs-Obese |
9.950000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.768400E-01 |
| Obese-vs-Extreme_Obese |
3.787400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.545000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.787400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.986400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.940400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.451000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.381770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.795600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.200410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.040400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.985580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.197400E-01 |
| Normal-VS-Type2 PRCC |
8.595400E-01 |
| Normal-VS-KIRP CIMP |
6.615200E-04 |
| Normal-VS-Unclassified PRCC |
8.128800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.285400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.975060E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.273400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.322800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.097000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.397500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.559200E-01 |
| Normal-vs-N1 |
3.220200E-01 |
| Normal-vs-N2 |
3.427000E-01 |
| N0-vs-N1 |
6.554000E-01 |
| N0-vs-N2 |
6.584400E-01 |
| N1-vs-N2 |
8.429000E-01 |
|
|
